Further evidence of infectious insults in the pathogenesis and pathophysiology of schizophrenia

American Journal of Psychiatry

Volumn 168, Issue 8, 2011, Pages 764-766

  Brown, Alans ^a,b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CANNABIS; IMMUNOGLOBULIN G;

ANTIBODY TITER; BETA HEMOLYTIC STREPTOCOCCUS; CENTRAL NERVOUS SYSTEM INFECTION; CHILDHOOD INJURY; CINGULATE GYRUS; DENMARK; DISEASE ASSOCIATION; EDITORIAL; ENVIRONMENTAL EXPOSURE; FETUS HYPOXIA; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; IMMUNE RESPONSE; INFECTION; INFECTION PREVENTION; INTRAUTERINE INFECTION; MATERNAL STRESS; MENTAL DISEASE; NONHUMAN; NUTRITIONAL DEFICIENCY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCHIZOPHRENIA; TOXOPLASMOSIS;

ADULT; ANIMALS; BRAIN; ENCEPHALITIS, HERPES SIMPLEX; FEMALE; HERPESVIRUS 1, HUMAN; HUMANS; IMMUNOGLOBULIN G; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY COMPLICATIONS, PARASITIC; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS; SCHIZOPHRENIA; TOXOPLASMA; TOXOPLASMOSIS, CONGENITAL;

EID: 80052515864     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2011.11050722     Document Type: Editorial

References (10)

1. Torrey E.F., Bartko J.J., Lun Z.R., Yolken R.H.: Antibodies to Toxoplasma gondii in patients with schizophrenia: A meta-analysis. Schizophr Bull 2007; 33:729-736 (Pubitemid 47343710)
2. Pedersen M.G., Stevens H., Pedersen C.B., Nørgaard-Pedersen B., Mortensen P.B.: Toxoplasma infection and later development of schizophrenia in mothers. Am J Psychiatry 2011; 168:814-821
3. Niebuhr D.W., Millikan A.M., Cowan D.N., Yolken R., Li Y., Weber N.S.: Selected infectious agents and risk of schizophrenia among US military personnel. Am J Psychiatry 2008; 165:99-106 (Pubitemid 351704558)
4. Prasad K.M., Eack S.M., Goradia D., Pancholi K.M., Keshavan M.S., Yolken R.H., Nimgaonkar V.L.: Progressive gray matter loss and changes in cognitive functioning associated with exposure to herpes simplex virus 1 in schizophrenia: A longitudinal study. Am J Psychiatry 2011; 168:822-830
5. Prasad K.M., Shirts B.H., Yolken R.H., Keshavan M.S., Nimgaonkar V.L.: Brain morphological changes associated with exposure to HSV1 in first-episode schizophrenia. Mol Psychiatry 2007; 12:105-113 (Pubitemid 44973667)
6. Brown A.S., Vinogradov S., Kremen W.S., Poole J.H., Deicken R.F., Penner J.D., McKeague I.W., Kochetkova A., Kern D., Schaefer C.A.: Prenatal exposure to maternal infection and executive dysfunction in adult schizophrenia. Am J Psychiatry 2009; 166:683-690
7. Birner P., Gatterbauer B., Drobna D., Bernheimer H.: Molecular mimicry in infectious encephalitis and neuritis: Binding of antibodies against infectious agents on western blots of human nervous tissue. J Infect 2000; 41:32-38 (Pubitemid 30649004)
8. Snider L.A., Swedo S.E.: PANDAS: Current status and directions for research. Mol Psychiatry 2004; 9:900-907 (Pubitemid 39381954)
9. Brown A.S.: The environment and susceptibility to schizophrenia. Prog Neurobiol 2011; 93:23-58
10. Hull C.M., Brunton S.: The role of topical 5% acyclovir and 1% hydrocortisone cream (Xerese™) in the treatment of recurrent herpes simplex labialis. Postgrad Med 2010; 122:1-6